Table 2.

Clinical trials of CC-220

Phase	Conditions	Interventions	NCT ID
1	Healthy volunteers	CC-220, placebo	NCT01733875
2	SLE	CC-220, placebo	NCT03161483
2	SLE	CC-220, placebo	NCT02185040
1,2	MM	CC-220, DEX, Dara, BTZ	NCT02773030
1	Healthy volunteers	CC-220	NCT03135509
1	Healthy volunteers	CC-220, radiation	NCT03294603
1	Hepatic impairment, Healthy volunteers	CC-220	NCT03824678

Abbreviation: SLE Systemic lupus erythematosus, DEX Dexamethasone, Dara Daratumumab, BTZ Bortezomib